Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study

The cerebrovascular safety and efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus (T2DM) with ischemic stroke remains uncertain. The aim of this study was to assess the efficacy and safety of sitagliptin in patients with T2DM with recent ischemic s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Chen, Dong-Yi, Wang, Szu-Heng, Mao, Chun-Tai, Tsai, Ming-Lung, Lin, Yu-Sheng, Su, Feng-Chieh, Chou, Chung-Chuan, Wen, Ming-Shien, Wang, Chun-Chieh, Hsieh, I-Chang, Hung, Kuo-Chun, Cherng, Wen-Jin, Chen, Tien-Hsing
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2015
Matèries:
5300
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4617065/
https://ncbi.nlm.nih.gov/pubmed/26181549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars